Baricitinib may not always prevent relapse in alopecia areata.
June 2024 in “Australasian Journal of Dermatology” Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.
May 2024 in “Frontiers in Medicine” Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.
March 2024 in “International Seven Journal of Health Research” Alopecia areata in children causes hair loss and needs a personalized treatment plan with medical and emotional support.
March 2024 in “INDIAN JOURNAL OF APPLIED RESEARCH” Polarity Analysis with Calcarea Carbonica may effectively treat alopecia areata with fewer side effects.
February 2024 in “Actas dermo-sifiliográficas/Actas dermo-sifiliográficas” Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.
February 2024 in “Journal of dermatology” CGF therapy may help hair regrowth and improve scars in DLE patients.
Combining baricitinib with golimumab helped regrow hair in a patient with ankylosing spondylitis and alopecia areata.
January 2024 in “Medicinska istrazivanja” Timely treatment of EPDS can reduce scarring.
December 2023 in “JAAD Case Reports” Intralesional corticosteroids effectively treat localized alopecia areata, often sparing white hairs.